Phaxiam
FranceEntry
2018
Hold
5yr
Exit
2023
Who owns Phaxiam?
Phaxiam was owned by Karista through Karista HealthTech Fund (2021 vintage) from 2018 to 2023, exited via IPO.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Exit Type
IPO
Buyer
MOIC
–
Exit Year
2023
More from Karista HealthTech Fund
Other portfolio companies in the same fund.
Switzerland
GermanyMore PE-backed in Healthcare
Comparable healthcare deals from other GPs.
US
Track Phaxiam
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Phaxiam?
1 strategic and 119financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Phaxiam.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue